Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 131-140 of 163 for

Edit search filters
  1. Mayo Clinic Cancer Genomics Service Line Biorepository

    Eau Claire, WI, Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Genetic Epidemiology of Glioma-International Consortium

    Rochester, MN

  3. A Study to Explore if it is Possible to Successfully Obtain Optical Coherence Tomography (OCT) Imaging and Data While Patients Undergo Brain Surgery

    Jacksonville, FL

  4. Blood Brain Barrier Differences in Patients With Brain Tumors Undergoing Surgery

    Rochester, MN

  5. Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

    Rochester, MN

  6. Cognitive Function After Treatment of Primary CNS Malignancy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. STAT3 Expression in Patients with Diffused Intrinsic Pontine Glioma (DIPG)

    Rochester, MN

  8. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

  9. A Study to Determine the Effects of COVID-19 in Cancer Patients

    Scottsdale/Phoenix, AZ, Mankato, MN, La Crosse, WI, Eau Claire, WI, Rochester, MN

  10. Brain Tumor Induced Immunosuppression

    Rochester, MN

.

Mayo Clinic Footer